List of SBIR/STTR awards granted to Elysium Therapeutics, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Elysium Therapeutics, Inc. in March, 2018 for $274,826.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA046302-01 | Phase I | 274,826 | March 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Elysium Therapeutics, Inc. in May, 2015 for $1,500,775.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DA037908-02 | Phase II | 1,500,775 | May 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Elysium Therapeutics, Inc. in August, 2017 for $2,962,537.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DA037908-04 | Phase II | 2,962,537 | August 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Elysium Therapeutics, Inc. in March, 2015 for $1,541,693.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DA037900-02 | Phase II | 1,541,693 | March 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Elysium Therapeutics, Inc. for $224,737.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DA037908-01 | Phase I | 224,737 | ||||||||
A SBIR Phase I contract was awarded to Elysium Therapeutics, Inc. for $217,526.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DA037900-01 | Phase I | 217,526 |
